Technology | Cardiac Resynchronization Therapy Devices (CRT)
Biotronik announced the availability of the first U.S. Food and Drug Administration (FDA)-approved cardiac rhythm management (CRM) devices with technology that automatically recognizes when a patient enters a magnetic resonance imaging (MRI) environment.
May 10, 2017
Technology | Leads Implantable Devices
Biotronik announced U.S. Food and Drug Administration (FDA) approval and the launch of Sentus ProMRI, the thinnest quadripolar left ventricular lead available in the United States. This introduction completes Biotronik's second-generation ProMRI lead portfolio, which also includes Solia ProMRI and Plexa ProMRI.
May 09, 2017
Technology | Cardiac Resynchronization Therapy Devices (CRT)
May 9, 2017 — The U.S. Food and Drug Administration (FDA) has cleared Boston Scientific’s Resonate family of implantable ...
May 09, 2017Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News
May 9, 2017 — The first patient has been enrolled in the U.S. Food and Drug Administration (FDA) approved prospective ...
May 09, 2017
News | EP Lab
May 9, 2017 — A manuscript by physicians from Mayo Clinic and Harvard Brigham & Women's Hospital entitled, “Initial ...
May 09, 2017
News | Venous Therapies
Medtronic plc recently announced three-year outcomes from the VeClose U.S. pivotal clinical trial and one-year data from the WAVES study. Both results were presented by Kathleen Gibson, M.D., of Lake Washington Vascular in Bellevue, Wash., at the 2017 Charing Cross Symposium in London. The new data demonstrate the clinical and quality of life benefits of the Medtronic VenaSeal closure system in treating patients with venous reflux disease.
May 05, 2017Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News | Cardiovascular Business
May 5, 2017 — Northwell Health recently announced that Cindy Grines, M.D., one of the nation’s pre-eminent cardiologists ...
May 05, 2017
Feature | Point of Care Testing | Nicholas C. Vanderslice, Ph.D., and Arnol S. Rios
Point-of-care (POC) coagulation analyzers that measure prothrombin time/international normalized ratio (PT/INR) on ...
May 05, 2017
News | Pharmaceuticals
A study of how policies restricting pharmaceutical promotion to physicians affect medication prescribing found physicians in academic medical centers (AMCs) prescribed fewer of the promoted drugs, and more non-promoted drugs in the same drug classes, following policy changes to restrict marketing activities at those medical centers. The analysis encompassed 16.1 million prescriptions; while the decline observed was modest in terms of percentage, proportionally small changes can represent thousands of prescriptions.
May 05, 2017Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
May 5, 2017 — DASpecialists LLC, a provider of data abstraction and support services for mandated or voluntary ...
May 05, 2017
Feature | Ventricular Assist Devices (VAD)
May 5, 2017 — Medtronic Mechanical Circulatory Support is expanding its recall of its HeartWare Ventricular Assist ...
May 05, 2017
News | Cardiovascular Surgery
Cedars-Sinai Heart Institute investigators have learned how cardiac muscle cells react to a certain type of injury that can be caused by open-heart surgery. The findings point to a new potential way to help these hearts recover more completely.
May 04, 2017Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News | Cardiovascular Business | Jeff Zagoudis
The U.S. House of Representatives on Thursday narrowly approved the American Health Care Act, the legislation designed by House Republican leadership and backed by President Donald Trump to replace the Affordable Care Act (ACA), also known as Obamacare.
May 04, 2017
News | Mobile Devices
Spok Inc. recently released the second part of the company's annual mobility in healthcare survey. Spok has been conducting this survey since 2011 to assess mobile workflow enablement trends in hospitals across the country. More than 300 U.S. healthcare professionals responded to this year’s questions about mobile strategy development, bring your own device (BYOD) policies, communications infrastructure and opportunities to improve mobile communications.
May 03, 2017
News | Heart Failure
American Regent, a member of the Daiichi Sankyo Group, announced that the first patient has been enrolled into the phase 3 clinical trial, HEART-FID. This double-blind, multicenter, prospective, randomized, placebo-controlled study will assess the efficacy and safety of iron therapy using intravenous (IV) ferric carboxymaltose (FCM), relative to placebo, in the treatment of patients with heart failure, iron deficiency and a reduced ejection fraction.
May 03, 2017© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now